|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | |||||||||||
| Restricted cash | |||||||||||
| Short-term deposits | |||||||||||
| Marketable securities | |||||||||||
| Accounts receivable, net of allowance for expected losses of $747 at December 31, 2025 and 2024 | |||||||||||
| Prepaid expenses and other current assets | |||||||||||
| Total current assets | |||||||||||
| Right-of-use assets | |||||||||||
| Property and equipment, net of accumulated depreciation of $584 and $405 at December 31, 2025 and 2024, respectively | |||||||||||
| Capitalized software costs, net of accumulated amortization of $3,391 and $810 at December 31, 2025 and 2024, respectively | |||||||||||
| Intangible assets, net of accumulated amortization of $3,568 and $2,008 at December 31, 2025 and 2024, respectively | |||||||||||
| Other non-current assets | |||||||||||
| Total assets | |||||||||||
| Liabilities and Stockholders' Deficit | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | |||||||||||
| Accrued interest | |||||||||||
| Accrued expenses | |||||||||||
| Deferred revenue | |||||||||||
| Current lease liabilities | |||||||||||
| Revolving credit facility, net | |||||||||||
| Derivative liability, current | |||||||||||
| Current portion of long-term debt, net | |||||||||||
| Total current liabilities | |||||||||||
| Long-term lease liabilities | |||||||||||
| Long-term debt, net | |||||||||||
| Derivative liability | |||||||||||
| Warrant liability | |||||||||||
| Other long-term liabilities | |||||||||||
| Total liabilities | |||||||||||
| Redeemable convertible preferred stock, Series C, par value $0.001; 160,000 shares authorized, 157,395 issued and outstanding in 2023 and 2022 | |||||||||||
| Stockholders deficit: | |||||||||||
| Common stock, par value $0.001; 500,000,000 shares authorized, 2,190,945 and 1,124,951 issued and outstanding at December 31, 2025 and 2024, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Accumulated other comprehensive loss | |||||||||||
| Total stockholders deficit | |||||||||||
| Total liabilities and stockholders deficit |
Loading...
